Back to funds
View filing
Pavaki Capital Management LLC
hedge fundUpdated 34 days agoManaged by Pavaki Capital Management Llc • Latest filing Q2 2026
Portfolio value
$286.8M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
61.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $142M |
| Q1 2026 | $235.4M |
| Q2 2026 | $286.8M |
Top holdings
163 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MIST MILESTONE PHARMACEUTICALS IN | $17.2M | 8.50M | 12.09% | — |
| 2 | R REGN REGENERON PHARMACEUTICALS | $15M | 19.4K | 10.54% | — |
| 3 | S SVM SILVERBACK THERAPEUTICS INC | $13.7M | 1.17M | 9.61% | — |
| 4 | B B BARRICK MNG CORP | $8.4M | 194.0K | 5.95% | — |
| 5 | D DIS DISNEY WALT CO | $6.9M | 61.0K | 4.89% | — |
| 6 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $5.9M | 202.0K | 4.13% | — |
| 7 | B BTG B2GOLD CORP | $5.2M | 1.16M | 3.68% | — |
| 8 | O OGN ORGANON & CO COMMON | $5.2M | 728.1K | 3.68% | — |
| 9 | T TXT TEXTRON INC | $3.7M | 42.7K | 2.62% | — |
| 10 | I INTC INTEL CORP | $3.7M | 100.0K | 2.60% | — |
| 11 | N NEMCL NEWMONT GOLDCORP CORPORATION | $3.2M | 32.5K | 2.29% | — |
| 12 | N NVDA NVIDIA CORPORATION | $3M | 16.0K | 2.10% | — |
| 13 | C CGAU CENTERRA GOLD INC | $2.8M | 197.0K | 1.99% | — |
| 14 | P PSKY PARAMOUNT SKYDANCE CORP COM | $2.8M | 208.9K | 1.97% | — |
| 15 | H HRMY HARMONY BIOSCIENCES HLDGS IN | $2.7M | 73.0K | 1.92% | — |
| 16 | D DOUG DOUGLAS ELLIMAN INC | $2.4M | 1.01M | 1.69% | — |
| 17 | L LGNYZ LIGAND PHARMACEUTICALS INC | $2.1M | 11.1K | 1.48% | — |
| 18 | B BIO-B BIO RAD LABS INC | $1.8M | 6.0K | 1.28% | — |
| 19 | R RPRX ROYALTY PHARMA PLC SHS | $1.7M | 44.0K | 1.20% | — |
| 20 | B BAIDF BAIDU INC SPON | $1.7M | 13.0K | 1.20% | — |